Key facts
- Truist lowered its price target for Medtronic.
- The adjustment is due to concerns about margin softness.
- This reflects a revised outlook on Medtronic's profitability.
Truist has reduced its price target for Medtronic, a prominent medical device company. The decision stems from concerns regarding margin softness, indicating a less optimistic view of the company's ability to maintain profitability. This adjustment by Truist signals a shift in the financial firm's assessment of Medtronic's financial performance and future prospects.